Table 1.
Baseline characteristics and outcome variables stratified according to 1-year mortality.
| Survivor (n = 866) | Non-survivor (n = 288) | p-value | |
|---|---|---|---|
| Sex (M/F) | 517/349 | 179/109 | 0.461 |
| Age (years) | 62.22 ± 15.88 | 68.49 ± 14.63 | < 0.001 |
| Cancer (n) | 109 (28.4%) | 131 (34.0%) | 0.104 |
| Postoperative patients (n) | 590 (68.1%) | 129 (44.8%) | < 0.001 |
| Emergency operation (n) | 147/590 (24.9%) | 33/129 (25.6%) | 0.874 |
| ICU readmission (n) | 36 (4.2%) | 30 (10.4%) | < 0.001 |
| APACHE II score | 14.91 ± 7.04 | 19.98 ± 9.03 | < 0.001 |
| SOFA score | 3.89 ± 3.16 | 5.92 ± 3.80 | < 0.001 |
| SAPS III | 27.21 ± 17.12 | 36.93 ± 21.43 | < 0.001 |
| Hb (g/dL) | 11.67 ± 6.00 | 10.46 ± 5.33 | 0.002 |
| WBC (103/µL) | 11,676.43 ± 5932.20 | 12,621.27 ± 6873.87 | 0.038 |
| Neutrophil (103/µL) | 9352.46 ± 5549.32 | 10,327.14 ± 5951.60 | 0.015 |
| Lymphocyte (103/µL) | 1445.35 ± 1858.15 | 1214.46 ± 1112.58 | 0.011 |
| NLR | 10.18 ± 10.68 | 16.26 ± 25.42 | < 0.001 |
| PLT (103/µL) | 196.00 ± 89.81 | 200.82 ± 146.45 | 0.598 |
| MPV | 10.16 ± 0.97 | 10.46 ± 1.13 | < 0.001 |
| MPV/platelet | 7.20 ± 11.78 | 8.97 ± 9.55 | 0.011 |
| Hospital stay (day) | 25.04 ± 58.00 | 28.10 ± 27.85 | 0.388 |
| ICU stay (day) | 4.67 ± 18.38 | 8.55 ± 13.28 | < 0.001 |
| Ventilator day (day) | 1.96 ± 18.11 | 6.02 ± 14.82 | < 0.001 |
Values are presented as the mean ± standard deviation or number of patients (%).
ICU, intensive care unit; APACHE II, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment; SAPS III, Simplified Acute Physiology Score; Hb, haemoglobin; WBC, white blood cell; NLR, neutrophil to lymphocyte ratio; PLT, platelet; MPV, mean platelet volume; HOD, hospital day.